Skip to content
10-K

Annual Report

AMERICAN BIO MEDICA CORPORATION

0001654954-22-005014

← back to feed
Filed
Apr 15, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Apr 14, 2022 48.1M sh
Capex FY 2021 · Dec 31, 2021 $0
Capex FY 2021 · Dec 31, 2020 $4K
Eps Basic FY 2021 · Dec 31, 2021 −$0.01
Eps Basic FY 2021 · Dec 31, 2020 −$0.02
Stock Issued FY 2021 · Oct 18, 2021 250K sh
Operating Cash Flow FY 2021 · Dec 31, 2020 −$483K
Cash And Equivalents FY 2021 · Dec 31, 2020 $98K
Cash And Equivalents FY 2021 · Dec 31, 2019 $4K
Current Liabilities FY 2021 · Dec 31, 2020 $2.02M
Total Liabilities FY 2021 · Dec 31, 2020 $3.18M
Current Assets FY 2021 · Dec 31, 2020 $1.18M
Total Assets FY 2021 · Dec 31, 2020 $1.93M
Sga Expense FY 2021 · Dec 31, 2020 $1.28M
Rd Expense FY 2021 · Dec 31, 2020 $90K
Net Income FY 2021 · Dec 31, 2020 −$796K
Net Income FY 2021 · Dec 31, 2020 −$796K
Operating Income FY 2021 · Dec 31, 2020 −$621K
Gross Profit FY 2021 · Dec 31, 2020 $1.24M
Cost Of Revenue FY 2021 · Dec 31, 2020 $2.91M
Revenue FY 2021 · Dec 31, 2020 $4.15M
Stockholders Equity FY 2021 · Jan 1, 2020 −$790K